Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Breakout Labs Backs Three Firms
by Lisa M. Jarvis
June 16, 2014
| A version of this story appeared in
Volume 92, Issue 24
Breakout Labs, a philanthropy started by entrepreneur Peter Thiel to support scientific start-ups, is adding three life sciences companies to its portfolio. Cortexyme will get funding to develop Alzheimer’s diagnostics and treatments based on work coming out of the labs of the University of California, San Francisco’s Stephen Dominy. G-Tech Medical is devising a wearable device that can monitor activity in the gastrointestinal tract. And EpiBone is using fat-derived stem cells to build living bone for patients. With the latest investments, Breakout Labs has 19 companies in its portfolio.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter